Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a full stack technology platform. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was founded in 2012 and is headquartered in New York, New York.
IPO Year: 2021
Exchange: NYSE
Website: hioscar.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $25.00 | Overweight | Piper Sandler |
5/30/2024 | $28.00 | Outperform | Robert W. Baird |
5/30/2024 | $25.00 → $21.00 | Buy → Neutral | BofA Securities |
3/22/2024 | $20.00 | Outperform | Raymond James |
11/2/2023 | $8.00 → $9.00 | Neutral → Buy | BofA Securities |
6/6/2023 | $5.40 → $8.75 | Underperform → Neutral | BofA Securities |
11/16/2022 | $4.00 | Equal Weight → Overweight | Wells Fargo |
11/14/2022 | $5.00 | Overweight → Equal-Weight | Morgan Stanley |
6/15/2022 | $6.00 → $4.50 | Neutral → Underperform | BofA Securities |
5/26/2022 | $12.00 → $6.00 | Buy → Neutral | BofA Securities |
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, today announced its leaders will present and provide a business update at three upcoming healthcare conferences: 2024 Wells Fargo Healthcare Conference: Chief Financial Officer, Scott Blackley, will participate in a fireside chat at approximately 12:45 p.m. ET on September 4, 2024. Morgan Stanley 22nd Annual Global Healthcare Conference: Chief Executive Officer, Mark Bertolini, will participate in a fireside chat at approximately 1:50 p.m. ET on September 5, 2024. Baird 2024 Global Healthcare Conference: Chief Financial Officer, Scott Blackley, will participate in a fireside chat at approximately 2:3
For the quarter ended June 30, 2024: Total Revenue of $2.2 billion, a 46% increase YoY Medical Loss Ratio of 79.0%, a 90 bps improvement YoY SG&A Expense Ratio of 19.6%, a 260 bps improvement YoY Net income attributable to Oscar of $56.2 million, or $0.20 of diluted earnings per share, a $71.7 million improvement YoY Adjusted EBITDA of $104.1 million, a $68.6 million improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results for the second quarter ended June 30, 2024. "Oscar reported strong second quarter results, closing out the best six months in the company's history," sa
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following August 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology pl
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced that Chief Financial Officer, Scott Blackley, is scheduled to present and provide a business update at the BofA Securities 2024 Global Health Care Conference on Wednesday, May 15, 2024 at approximately 8:40 AM PT (11:40 AM ET) in Las Vegas, NV. All interested parties are invited to listen to a live webcast of the fireside chat by visiting www.ir.hioscar.com and selecting the "Events & Presentations" link. Following the presentation, a webcast replay will be available on Oscar's investor relations website for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Os
For the quarter ended March 31, 2024: Total Revenue of $2.1 billion, a 46% increase YoY Medical Loss Ratio of 74.2%, a 210 bps improvement YoY SG&A Expense Ratio of 18.4%, an 870 bps improvement YoY Net Income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share, a $217.1 million improvement YoY Adjusted EBITDA of $219.3 million, a $168.2 million improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results for the first quarter ended March 31, 2024. "Oscar reported strong first quarter results, showing year-over-year improvement across all core metri
Early Stage VC Firm Created by Oscar Health Founding Team Now Manages more than $150 Million in Assets Floating Point, an early stage venture capital firm investing in complex sectors, today announced the closing of its $70 million second fund. Floating Point looks deep in overlooked sectors to back expert founders building first of their kind companies. Their portfolio includes category-defining companies such as Altana, Commons Clinic, Sun Day, Floodbase, and Wheeler Bio. Floating Point now manages more than $150 million in assets on behalf of a wide range of institutional, private equity, and family office investors including 53 Stations, the venture arm of The Pritzker Organization.
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will host its 2024 Investor Day on Friday, June 7, 2024 in New York City. Management will discuss the Company's corporate strategy, financial performance, and long-term financial targets. The event will begin at 9:00 AM ET. A live webcast to the presentation and the presentation materials will be available on Oscar's investor relations website (www.ir.hioscar.com). The webcast will be archived on Oscar's investor relations website following June 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stac
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following May 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a relentless
For the year ended December 31, 2023: Direct and Assumed Policy Premiums of $6.6 billion, a 3% decrease YoY Premiums earned of $5.7 billion, a 47% increase YoY Medical Loss Ratio of 81.6%, a 370 bps improvement YoY InsuranceCo Administrative Expense Ratio of 17.9%, a 270 bps improvement YoY InsuranceCo Combined Ratio of 99.5%, a 640 bps improvement YoY Adjusted Administrative Expense Ratio of 21.0%, a 350 bps improvement YoY Net loss of $271 million, an improvement of $339 million YoY Adjusted EBITDA loss of $45 million, an improvement of $417 million YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today a
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment. The awards were granted under Oscar's 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
4 - Oscar Health, Inc. (0001568651) (Issuer)
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment. The awards were granted under Oscar's 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare. Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven Kelmar will join as Executive Vice President and Chief of Staff to the CEO, effective September 21, 2023. In her role, Sain oversees the go-to-market strategy for the +Oscar business and will work closely with Mario Schlosser, President of Technology and Chief Technology Officer, to continue externa
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, today announced that Dr. Sean Martin, MD has been appointed to serve as the company's new Chief Medical Officer, effective immediately. Dr. Martin joined Oscar in 2016 and during his tenure has provided clinical leadership across a number of core clinical functions, including enterprise affordability, medical management, market performance, population health, and behavioral health. In his new role, he will be responsible for implementing Oscar's clinical capabilities and enhancing the quality of care and outcomes for its members. "Dr. Martin is an avid champion of the us
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, today announced that Bill Gassen and Laura Lang have been appointed to its Board of Directors. They have joined the board in an official capacity effective today, December 7, 2022. Ms. Lang was also appointed as Chair of the Compensation Committee of the Board and Mr. Gassen was also appointed as a member of the Nominating and Corporate Governance Committee of the Board. "We are thrilled to welcome Bill and Laura to Oscar's Board of Directors," said Mario Schlosser, CEO and Co-Founder of Oscar. "Their collective experience across industries will bring invaluable expertise
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G - Oscar Health, Inc. (0001568651) (Subject)
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)
SC 13G - Oscar Health, Inc. (0001568651) (Subject)
Piper Sandler analyst Jessica Tassan maintains Oscar Health (NYSE:OSCR) with a Overweight and maintains $25 price target.
Across the recent three months, 7 analysts have shared their insights on Oscar Health (NYSE:OSCR), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 2 1 0 0 2M Ago 1 1 1 0 0 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $24.43, along with a high estimate of $28.00 and a low estimate of $21.00. Marking
Piper Sandler analyst Jessica Tassan initiates coverage on Oscar Health (NYSE:OSCR) with a Overweight rating and announces Price Target of $25.
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. Below are some instances of options activity happening in the Financials sector: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume OSCR CALL SWEEP BULLISH 07/19/24 $21.00 $29.9K 5.8K 3.3K COIN CALL TRADE BEARISH 06/21
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the price target from $24 to $27.
Ratings for Oscar Health (NYSE:OSCR) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 2 0 0 Last 30D 0 1 1 0 0 1M Ago 1 1 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $23.17, with a high estimate of $28.00 and a low estimate of $20.00. Marking an increase of 11.66%, the cu
B of A Securities analyst Adam Ron downgrades Oscar Health (NYSE:OSCR) from Buy to Neutral and lowers the price target from $25 to $21.
Baird analyst Michael Ha initiates coverage on Oscar Health (NYSE:OSCR) with a Outperform rating and announces Price Target of $28.
B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Buy and raises the price target from $22 to $25.
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. Below are some instances of options activity happening in the Financials sector: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume UPST CALL SWEEP BEARISH 06/21/24 $30.00 $30.4K 5.4K 3.7K OSCR CALL SWEEP BEARISH 05/17
Piper Sandler initiated coverage of Oscar Health with a rating of Overweight and set a new price target of $25.00
Robert W. Baird initiated coverage of Oscar Health with a rating of Outperform and set a new price target of $28.00
BofA Securities downgraded Oscar Health from Buy to Neutral and set a new price target of $21.00 from $25.00 previously
Raymond James initiated coverage of Oscar Health with a rating of Outperform and set a new price target of $20.00
BofA Securities upgraded Oscar Health from Neutral to Buy and set a new price target of $9.00 from $8.00 previously
BofA Securities upgraded Oscar Health from Underperform to Neutral and set a new price target of $8.75 from $5.40 previously
Wells Fargo upgraded Oscar Health from Equal Weight to Overweight and set a new price target of $4.00
Morgan Stanley downgraded Oscar Health from Overweight to Equal-Weight and set a new price target of $5.00
BofA Securities downgraded Oscar Health from Neutral to Underperform and set a new price target of $4.50 from $6.00 previously
BofA Securities downgraded Oscar Health from Buy to Neutral and set a new price target of $6.00 from $12.00 previously
8-K - Oscar Health, Inc. (0001568651) (Filer)
144 - Oscar Health, Inc. (0001568651) (Subject)
10-Q - Oscar Health, Inc. (0001568651) (Filer)
8-K - Oscar Health, Inc. (0001568651) (Filer)
8-K - Oscar Health, Inc. (0001568651) (Filer)
8-K - Oscar Health, Inc. (0001568651) (Filer)
144 - Oscar Health, Inc. (0001568651) (Subject)
10-Q - Oscar Health, Inc. (0001568651) (Filer)
8-K - Oscar Health, Inc. (0001568651) (Filer)
ARS - Oscar Health, Inc. (0001568651) (Filer)
For the quarter ended June 30, 2024: Total Revenue of $2.2 billion, a 46% increase YoY Medical Loss Ratio of 79.0%, a 90 bps improvement YoY SG&A Expense Ratio of 19.6%, a 260 bps improvement YoY Net income attributable to Oscar of $56.2 million, or $0.20 of diluted earnings per share, a $71.7 million improvement YoY Adjusted EBITDA of $104.1 million, a $68.6 million improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results for the second quarter ended June 30, 2024. "Oscar reported strong second quarter results, closing out the best six months in the company's history," sa
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following August 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology pl
For the quarter ended March 31, 2024: Total Revenue of $2.1 billion, a 46% increase YoY Medical Loss Ratio of 74.2%, a 210 bps improvement YoY SG&A Expense Ratio of 18.4%, an 870 bps improvement YoY Net Income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share, a $217.1 million improvement YoY Adjusted EBITDA of $219.3 million, a $168.2 million improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results for the first quarter ended March 31, 2024. "Oscar reported strong first quarter results, showing year-over-year improvement across all core metri
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following May 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a relentless
For the year ended December 31, 2023: Direct and Assumed Policy Premiums of $6.6 billion, a 3% decrease YoY Premiums earned of $5.7 billion, a 47% increase YoY Medical Loss Ratio of 81.6%, a 370 bps improvement YoY InsuranceCo Administrative Expense Ratio of 17.9%, a 270 bps improvement YoY InsuranceCo Combined Ratio of 99.5%, a 640 bps improvement YoY Adjusted Administrative Expense Ratio of 21.0%, a 350 bps improvement YoY Net loss of $271 million, an improvement of $339 million YoY Adjusted EBITDA loss of $45 million, an improvement of $417 million YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today a
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following February 7, 2024 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology
For the quarter ended September 30, 2023: Direct and Assumed Policy Premiums of $1.6 billion, a 5% decrease YoY Premiums earned of $1.4 billion, a 46% increase YoY Medical Loss Ratio of 83.8%, a 608 bps improvement YoY Net loss of $65.7 million, an improvement of $127.8 million YoY Adjusted EBITDA loss of $20.3 million, an improvement of $139.5 million YoY InsuranceCo Administrative Expense Ratio of 17.4%, a 326 bps improvement YoY InsuranceCo Combined Ratio of 101.3%, a 934 bps improvement YoY Adjusted Administrative Expense Ratio of 20.3%, a 443 bps improvement YoY Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology comp
For the quarter ended June 30, 2023: Direct and Assumed Policy Premiums of $1.6 billion, a 3% decrease YoY Premiums earned of $1.5 billion, a 48% increase YoY Medical Loss Ratio of 79.9%, a 230 bps improvement YoY Net loss of ($15.4) million, an improvement of $96.7 million YoY Adjusted EBITDA of $35.6 million, an improvement of $111.4 million YoY InsuranceCo Administrative Expense Ratio of 16.7%, a 280 bps improvement YoY InsuranceCo Combined Ratio of 96.7%, a 500 bps improvement YoY Adjusted Administrative Expense Ratio of 19.5%, a 420 bps improvement YoY Health tech company Oscar Health, Inc. (NYSE:OSCR) today announced its financial results for the second q
Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, will release its second quarter 2023 financial results after market close on Tuesday, August 8, 2023. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.hioscar.com) following August 8, 2023. About Oscar Health Oscar Health, Inc. ("Oscar") is the first health insurance company built around a full stack technology platform and a
For the quarter ended March 31, 2023: Direct and Assumed Policy Premiums of $1.7 billion, a 2% increase YoY Premms earned of $1.4 billion, a 50% increase YoY Medical Loss Ratio of 76.3%, a 108 bps improvement YoY Net loss of $39.6 million, an improvement of $37.7 million YoY Adjusted EBITDA of $51.1 million, an improvement of $88.1 million YoY InsuranceCo Administrative Expense Ratio of 18.6%, a 121 bps improvement YoY InsuranceCo Combined Ratio of 94.9%, a 230 bps improvement YoY Adjusted Administrative Expense Ratio of 21.7%, a 206 bps improvement YoY Health tech company Oscar Health, Inc. (NYSE:OSCR) today announced its financial results for the first quarte